Evidence map›Paper›PMID 38454019›Full record

ArticleScientific reports2024

Publisher Correction: Suspect screening analysis to improve untargeted and targeted UHPLC-qToF approaches: the biodegradability of a proton pump inhibitor medicine and a natural medical device.

Luisa Mattoli, Giacomo Proietti, Giada Fodaroni, Claudio Marzio Quintiero, Michela Burico, Mattia Gianni, Emiliano Giovagnoni, Valentino Mercati, Claudio Santi

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Luisa Mattoli *Metabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.ORCID http://orcid.org/0000-0002-5566-8919
Giacomo Proietti *Metabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.
Giada FodaroniMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.
Claudio Marzio QuintieroMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.
Michela BuricoMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.ORCID http://orcid.org/0000-0002-6243-9073
Mattia GianniMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.ORCID http://orcid.org/0009-0004-2955-8240
Emiliano GiovagnoniMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.
Valentino MercatiMetabolomics and Analytical Sciences, Aboca SpA, Sansepolcro, AR, Italy.
Claudio SantiGroup of Catalysis, Synthesis and Organic Green Chemistry, Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123, Perugia, Italy. claudio.santi@unipg.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38454019
PMCPMC10920894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.